Literature DB >> 1395829

Antithrombotic agents in coronary artery disease.

J A Cairns, J Hirsh, H D Lewis, L Resnekov, P Théroux.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1395829     DOI： 10.1378/chest.102.4_supplement.456s

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  3 in total

Review 1.  Intravenous heparin dosing: patterns and variations in internists' practices.

Authors:  B M Reilly; R Raschke; S Srinivas; T Nieman
Journal:  J Gen Intern Med       Date:  1993-10       Impact factor: 5.128

2.  Coumadin Aspirin Reinfarction Study: Rationale and Design of the CARS Study.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1995       Impact factor: 2.300

3.  Prevention of thrombosis and rethrombosis and enhancement of the thrombolytic actions of recombinant tissue-type plasminogen activator in the canine heart by DMP728, a glycoprotein IIb/IIIa antagonist.

Authors:  B R Lucchessi; W E Rote; E M Driscoll; D X Mu
Journal:  Br J Pharmacol       Date:  1994-12       Impact factor: 8.739
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.